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RESUMO 
 
Introdução: Nos últimos anos, os protocolos ERAS (enhanced recovery after surgery), 
protocolos de recuperação pós-cirúrgica melhorada, têm vindo a ser crescentemente 
integrados nos cuidados peri-operatórios de doentes submetidos a cirurgia digestiva. 
Objetivos: Realizar uma revisão bibliográfica não sistemática relativa à integração dos 
protocolos de recuperação pós-cirúrgica melhorada (ERAS) no contexto da 
gastrectomia, da cirurgia do colón e do reto, e avaliar o impacto dos mesmos nos 
resultados pós-operatórios.  
Métodos: A pesquisa fundamentou-se na base de dados do PubMed, que identificou 
estudos focados na integração dos protocolos de recuperação pós-cirúrgica melhorada 
(ERAS) na prática clinica, e nos resultados da mesma. Trinta e sete estudos cumpriram 
os critérios de inclusão e foram revistos, entre o período de 2007 e 2017. 
Resultados: Os protocolos de recuperação pós-cirúrgica melhorada (ERAS) 
demonstraram reduzir o tempo até ao retorno da função intestinal e a duração da 
estadia hospitalar por pelo menos um dia, comparando com os cuidados peri-
operatórios convencionais, na cirurgia colorretal e gastrectomia por cancro do 
estomago. Resultados ótimos foram atingidos quando as taxas de cumprimento dos 
protocolos foram máximas. 
Conclusões: Os protocolos de recuperação pós-cirúrgica melhorada (ERAS) podem ser 
implementados de modo seguro na cirurgia colorretal e na gastrectomia por cancro do 
estomago. Estão associados a resultados melhorados. Uma implementação adequada, 
com altas taxas de cumprimento dos protocolos, é um passo em direção a uma 
recuperação acelerada e ao retorno rápido dos doentes às suas atividades basais. 
 
  
 6 
ABSTRACT 
 
Introduction: In recent years, enhanced recovery after surgery protocols have 
increasingly been integrated into perioperative care of patients undergoing digestive 
surgery.  
Aims: To conduct a non-systematic literature review related to the integration of 
enhanced recovery after surgery protocols in elective gastrectomy, colonic and rectal 
surgery, and the impact this had on outcomes. 
Methods: The PubMed database was searched to identify studies that focused on the 
integration of enhanced recovery after surgery protocols in clinical practice, as well as 
their outcomes. 37 studies fulfilled the inclusion criteria and were reviewed accordingly 
between the years of 2007 and 2017. 
Results: The enhanced recovery after surgery pathway has shown to reduce time to 
return of bowel function and to minimize length of hospital stay by at least one day, when 
compared to conventional care, in colorectal surgery and gastrectomy for gastric cancer. 
Optimal results are achieved with maximum compliance rates. 
Conclusions: The enhanced recovery after surgery protocols may be safely 
implemented in colorectal surgery and gastrectomy for gastric cancer, producing 
improved patient outcomes. An adequate integration of the enhanced recovery after 
surgery protocols in these areas, with a high compliance rate, is a step towards a faster 
return of patients to their baseline activity. 
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INTRODUCTION 
 
Despite steady advances in surgical and anesthetic techniques over the years, 
postoperative complications remain one of the major concerns regarding surgical 
procedures, not only because of the impact on the patient, but also on the health care 
system in general. 
The ERAS programs, originally based on the “fast track” surgery concept introduced 
by Henrik Kehlet [1], were developed as multimodal perioperative pathways that include 
multiple interventions that individually produce small insignificant effects, but collectively 
have a strong synergistic impact on the patients' homeostasis[2]. These protocols strike 
to attenuate the metabolic stress through perioperative measures, and simultaneously to 
support the patient’s rapid return to baseline function, producing therefore a decrease in 
complication rates and lessening the recovery time after surgery. 
The present literature review aims to gather current scientific knowledge regarding 
outcomes of ERAS programs in digestive surgery. It was considered important to first 
briefly review the ERAS items, as it allows for a better comprehension of results.  This 
review focuses on elective digestive surgery, more specifically on gastrectomy and 
colorectal surgery, for which the ERAS Society published guidelines for perioperative 
care. 
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MATERIALS AND METHODS 
 
This literature review is based on a PubMed search with the following instructions: 
Title/abstract: (“enhanced recovery after surgery” OR “eras”) AND (“gastrectomy” OR 
“gastric” OR “colon” OR “colonic” OR “ colorectal” OR “rectal”). The following filters were 
applied to the search: species: human; date: 2007-2017. 
 
From the 131 articles found, 37 were selected for review. The excluded papers 
regarded non-elective surgery (e.g. emergency context), surgery of fields other than 
colorectal and gastric (bariatric surgery not included), studies that focused on the elderly 
or on the pediatric population, studies that used modified ERAS protocols, publications 
related to cost-effectiveness of ERAS protocol implementations, studies in languages 
other than English/Spanish/Portuguese or because they did not adjust to the topics 
reviewed in this article. No procedure specific ERAS items have been revised. 
 
Additional articles were referenced as they were found relevant for the debate of the 
state of the art of the subject. 
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RESULTS 
 
Surgical Stress 
 
The stress response to surgery is activated through the nervous system, which mainly 
results in hematological, immunological and endocrinological responses. The extent of 
this response correlates with the degree of tissue injury, which may be posteriorly 
amplified by postoperative complications[2, 3]. 
Stress response is proportional to the extension of the surgical wound, the degree of 
internal organ manipulation and tissue dissection and reflects increased demands on 
organ function[2]. 
The hormonal changes produced result, as an overall, in a hypermetabolic status 
where most biochemical reactions are accelerated. In evolutionary terms, it seems likely 
that this stress response was developed as a protective mechanism that aims to provide 
maximum chances of survival, through the increase of cardiovascular functions, volume 
preservation and mobilization of substrates[3-5]. In current surgical and anesthetic 
practice, it is questionable if this stress response is necessary as it turns out that a 
prolonged hypermetabolic state may result in the body’s exhaustion, causing loss of 
weight, decreased resistance, delayed ambulation and increased morbidity and 
mortality[3, 5]. This considered, in modern surgical practice, efforts are made to minimize 
the stress response[6]. 
 
Minimizing Surgical Injury through the ERAS Pathway 
 
The ERAS pathway strike to attenuate the physiological stress response to surgery 
and maintain preoperative organ function. The ERAS protocols include measures 
integrated before, during and after the surgical procedure. 
Preoperative Items: 
 
- Information, education and counseling: 
Preoperative anxiety, emotional distress and depression have been associated with 
higher complication rates, greater postoperative pain, cognitive disturbances and 
delayed convalescence[2]. 
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Giving the patient, as well as of the caregivers, information about the surgical and 
anesthetic procedures is essential to reduce anxiety and to facilitate active participation 
in the recovery process[2, 7-9]. Indicating specific daily targets for the postoperative 
period may facilitate eating, mobilization, pain control and respiratory function, therefore 
reducing complication risk[8]. 
In the case of patients undergoing rectal surgery, it is important to add specific 
information regarding the marking and management of stomas[9]. 
 
- Preoperative medical optimization: 
The impact of preoperative physical conditioning on surgical outcomes is 
controversial, and increasing exercise preoperatively may benefit the patient’s 
recovery[7-9]. 
Preoperative optimization also involves alcohol and smoking cessation and 
abstinence for at least 4 weeks before the surgery, to reduce the incidence of 
complications related to these habits[7-10]. Alcohol abusers have a two-to-threefold 
increase in postoperative morbidity, the most frequent complications being bleeding, 
wound and cardiopulmonary complications. Smokers have an increased risk for 
postoperative pulmonary and wound complications[7] 
 
- Fasting and carbohydrate loading 
Standard care follows fasting guidelines supported by multiple anesthesia societies, 
that recommend that clear fluids and solid food should not be ingested 2h and 6h, 
respectively, before the induction of anesthesia. Although this is the recommendation, it 
is not uncommon for patients scheduled for elective surgery to fast since midnight[7, 10]. 
There is no scientific evidence that fasting from midnight reduces the risk of pulmonary 
aspiration in elective surgery[7], and this practice has been shown to increase insulin 
resistance, produce patient discomfort[8] and potentially decrease intravascular 
volume[7, 10]. 
Preoperative treatment with complex carbohydrate (CHO) drinks attenuates the 
catabolic state induced by overnight fasting and surgery, allowing patients to undergo 
surgery in a metabolically fed state[9]. The increase of preoperative insulin levels, 
reduces postoperative insulin resistance[9], maintains glycogen reserves, decreases 
protein breakdown and reduces the loss of muscle strength[2, 7, 9, 10]. In addition to 
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this, treatment with CHOs also has been shown to reduce preoperative thirst, hunger 
and anxiety[7, 9]. Faster surgical recovery, as a consequence of this practice, still 
remains controversial[10]. 
Preoperative treatment with CHO drinks, following the “preoperative fasting status” 
ASA recommendations, is advised for all non-diabetic patients[9], and may be safely 
administered except in emergency surgeries[10, 11], and in patients with documented 
delayed gastric emptying or gastrointestinal motility disorders[10, 11]. Obese patients 
have been shown to have the same gastric-emptying characteristics as slim individuals. 
Diabetic patients with neuropathic affectation may have delayed gastric emptying for 
solids, which may increase the risk of regurgitation and aspiration. There isn’t any 
conclusive data relating to delayed fluid emptying. In diabetic patients without 
neuropathy, gastric emptying has been reported as normal, and CHO drinks may be 
given along with diabetic medication[7]. 
 
- Bowel preparations 
Lately, the use of mechanical bowel preparation (MBP) has been strongly questioned. 
This practice, not only is distressing to the patient, but also causes dehydration and is 
associated with prolonged ileus after colonic surgery. In addition to this, the use of 
MBPs, on colorectal surgery, has been shown to increase the incidence of spillage of 
bowel contents, increasing the risk of postoperative complications[7]. However, when a 
diverting ileostomy is planned, MBP may be necessary[9]. If, for any reason, 
intraoperative colonoscopy might be carried out, MBP is also advised.  
Most of the randomized control trials conducted on this matter, are focused on open 
colorectal surgery, therefore, extrapolating these results to laparoscopic surgery may be 
questionable[7].  
According to ERAS Society recommendations, in gastrectomy, MBP should not be 
used[8].  
 
- Antibiotic prophylaxis and skin preparation 
The use of prophylactic antibiotics with aerobic and anaerobic coverage, in colorectal 
surgery, has shown to reduce postoperative infectious complications. In gastrectomy and 
colorectal surgery, intravenous antibiotics should ideally be administrated 30-60mins 
before the first surgical incision[7, 8]. A multidose regimen may be preferred in prolonged 
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surgeries (>3h), whenever it is appropriate considering the antibiotic’s 
pharmacokinetics[7-9]. The optimal combination of antibiotics is still not defined, 
however the combination of metronidazole and an aerobic antibiotic is often 
recommended. New generation drugs should be reserved for infectious complications[9]. 
A study comparing the use of povidone-iodine and chlorhexidine-alcohol in skin 
cleansing concluded that the latter is superior in preventing infectious complications[8, 
9],  being associated with a 40% lower prevention of surgical site infections. The use of 
chlorhexidine-alcohol, however, may be a risk factor for burn injuries whenever 
diathermy is used[7]. 
 
- Thromboprophylaxis 
All patients undergoing abdominal or pelvic surgery should receive mechanical 
thromboprophylaxis with well-fitted stockings, as they have been shown to significantly 
reduce the incidence of deep venous thrombosis (DVT) in hospitalized patients. 
Intermittent pneumatic compression should be considered, above all, in patients with risk 
factors for thromboembolic events[7-9]. Risk factors include previous pelvic surgery, 
preoperative treatment with corticosteroids, malignant disease[7, 9], major surgery, long 
periods of recumbency, chemotherapy[8]  and other hypercoagulable states. 
The benefits of pharmacological prophylaxis with low-molecular-weight heparin 
(LMWH) or unfractionated heparin in the prevention of venous thromboembolism are 
well established[7, 8], they reduce the prevalence of symptomatic venous 
thromboembolism (VTE) without increasing side effects such as bleeding[9]. However, 
the benefit of extended (28 days) prophylaxis after discharge, is less consensual. 
Extended prophylaxis has been shown to significantly reduce the prevalence of 
symptomatic DVT, but, due to a very low prevalence of this complication in patients who 
did not receive prophylactic treatment, it is questionable whether a large number of 
patients should receive thromboprophylaxis to prevent a few symptomatic events[7]. 
Current ERAS Society guidelines advocate that this treatment should be reserved for 
patients who had major cancer surgery in the abdomen or pelvis or who have other 
important risk factors for VTE[7]. 
It is unknown if the implementation of ERAS protocols and/or the use of laparoscopic 
surgery, through the promotion of an early recovery, reduce the risk of VTE and, 
therefore, the need for pharmacological prophylaxis[9]. 
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Incidence of asymptomatic DVT in colorectal surgical patients without 
thromboprophylaxis is approximately 30%, with fatal pulmonary embolus occurring in 1% 
of individuals[7]. 
 
- Preanesthesia medication 
Data from studies on abdominal surgery, show no evidence of clinical benefit from 
preoperative use of long-acting sedatives[8]. Their administration is associated with 
impaired postoperative mobilization and direct participation, resulting in prolonged length 
of stay in hospital (LOSH)[7, 10]. Short-acting anesthetic drugs (e.g. fentanyl combined 
with small incremental doses of midazolam or propofol) may be safely administered, 
under monitorization, to facilitate anesthetic procedures (e.g. epidural or spinal 
anesthesia) previously to the induction of anesthesia, with minimal residual effect at the 
end of surgery[7]. 
Preoperative education and counseling may help reduce the need for anxiolytic 
medication, as well as other ERAS elements, such as the avoidance of MBP and 
prolonged fasting, and preoperative treatment with CHOs[7]. 
 
Intraoperative Items: 
 
- Laparoscopy 
Laparoscopy is a minimally invasive surgical technique that has been shown to 
decrease inflammatory response to surgery when compared to open approaches. The 
ERAS Society guidelines recommend that proctectomy and proctocolectomy for benign 
disease, colonic resection and early gastric cancer gastrectomy be done 
laparoscopically, if an experienced surgeon is available. In this setting, laparoscopic 
surgery has shown to be safe and may lower hospital stay and decrease complication 
rates. However, ERAS Society guidelines do not recommend laparoscopic resection of 
rectal cancer outside a trial setting, due to lack of equivalent data on oncological 
outcomes, nor laparoscopically assisted total gastrectomy for advanced cancer, as there 
is inconclusive data as to the safety of this procedure[7-9]. 
- Anesthetic management 
Although there are no trials comparing general anesthetic techniques for 
gastrointestinal surgery[7, 8, 10], ERAS protocols aim for a minimal impact of anesthetic 
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agents and techniques on organ function, and for a rapid awakening, allowing an early 
return to baseline activity[10]. To do so, it is sensible to assume that short-acting agents 
should be preferred. 
Short-acting induction agents, such as propofol, combined with short-acting opioids, 
such as fentanyl or remifentanil, are widely used, as well as short-acting muscle 
relaxants[7, 8, 10]. Recently, a review on the use of continuous intravenous lidocaine 
infusion in the perioperative of abdominal surgery concluded that it provides significant 
pain relief, reduces postoperative opioid consumption, decreases opioid-induced nausea 
and vomiting, and promotes a faster return of bowel function, allowing for reduced 
LOSH. There is a continuous effort to reduce opioid administration because they are 
associated with several complications, such as respiratory depression, sedation, 
postoperative nausea and vomiting (PONV), ileus and urinary retention[12]. A recent 
RCT in patients undergoing colorectal surgery with the ERAS program, showed no 
difference between continuous lidocaine infusion and thoracic epidural analgesia (EDA), 
in return of bowel movements and LOSH, whilst another RCT focused on patients 
undergoing laparoscopic gastrectomy showed a reduction in postoperative fentanyl 
consumption and pain with lidocaine infusion by patient-controlled analgesia (PCA)[8]. 
Muscle relaxants can be titrated using neuromuscular monitoring, allowing for 
administration of the minimal dose necessary to produce the intended effect. The 
maintenance of a deep neuro-muscular blockage is essential to allow adequate vision 
and surgical access[7], particularly in laparoscopic surgery[8]. Despite this, reversal of 
profound muscle relaxation, can occasionally be incomplete. In these cases, the use of 
sugammadex to counter act the action of large doses of muscle relaxants, has proven to 
facilitate recovery[9]. 
The maintenance of anesthesia can be made using inhalation anesthetics or 
intravenous anesthesia, in which case, target controlled pumps may be used. These are 
especially useful in patients with susceptibility to PONV[7]. Short-acting agents should 
also be used in maintaining anesthesia, always adjusted the estimated duration of 
surgery. 
Depth of induction and maintenance anesthesia can be monitored using the 
bispectral index (BIS) monitor, which enables titration of the minimum amount of 
anesthetic necessary to avoid complications[7-10]. Anesthetic depth guided by BIS is a 
key aspect in preventing awareness and in allowing for a faster immediate recovery, 
although time to discharge home seems unaffected[10]. To this effect, BIS index should 
be between 40 and 60. Studies have highlighted that too deep anesthesia should be 
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avoided, as this reflects increased suppression of brain activity and can lead to 
postoperative confusion, mainly in the elderly[10]. 
Regional anesthetic blockage, used in addition to general anesthesia, can minimize 
the need for postoperative intravenous opiates and reduce the stress response. This 
includes a reduction in insulin resistance, an important causing mechanism of 
postoperative hyperglycemia[7]. 
Another important component of the anesthetic management is the regulation of 
ventilation and airway. Attention to intubation techniques is important to reduce risk of 
micro-aspiration and subsequent postoperative lung infection. To this end, adequate  
sized endotracheal tubes with cuff-pressure control should be used[7]. Lung ventilation 
with low tidal volumes, limiting peak air pressure, is suggested to reduce the risk of 
barotraumas[9].  
Surgical stress demands for an increased fraction of inspired oxygen, to overcome 
hypoxia under anesthesia. It has been suggested that, in patients undergoing general 
anesthesia, high inspired oxygen concentrations (> 80%[9])  reduces the prevalence of 
surgical site infections. Other than this, it is also said to reduce the incidence of late 
(>24h postoperatively) nausea and vomiting, in patients receiving volatile anesthesia 
without antiemetic prophylaxis[10]. It has been suggested that excessive use of high 
concentrations of inspired oxygen on cancer patients undergoing abdominal surgery can 
have deleterious long-term effects and that using 100% inspired oxygen may be 
associated with an increased risk of atelectasis. Therefore, inspired oxygen 
concentration should be titrated to produce normal oxygen saturations, avoiding both 
hypoxia and hyperoxia[10]. 
 
- Regional anesthetic techniques 
 
Insertion of a thoracic epidural catheter is useful in open and laparoscopic procedures 
to provide improved pain management. Local anesthetics can be administered 
throughout the procedure, either in bolus or in a continuous infusion[9]. An optimal 
postoperative analgesia provides an adequate pain relief, early mobilization, early return 
of gut function and feeding, without associated side effects[7]. Interestingly, a RCT[13] in 
context of colectomy, showed that, although EDA produces superior pain control, LOSH 
is not reduced[7].  
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For open midline laparotomy, EDA has been established as the ideal. EDA using 
local analgesics (e.g. lidocaine) and low-dose opioids has shown to be superior to 
intravenous opioid-based alternatives, regarding outcomes such as postoperative pain[7, 
8] (superior analgesia in the first 72h following surgery), PONV and pulmonary 
complications[7]. In this context, EDA was also associated with improved postoperative 
pulmonary function, decreased risk of pneumonia, improved arterial oxygenation, 
reduced insulin resistance and a lower rate of postoperative ileus[8].  
 
In laparoscopic surgery, studies regarding colorectal surgery have shown that 
different epidural blockage levels produce different effects on gastrointestinal function: 
low-thoracic epidural wasn’t associated with benefits, on the contrary, mid-thoracic 
epidural showed significantly earlier return of flatus, defecation and tolerance of oral diet, 
when compared to intravenous opioid analgesia[7]. Another study[14], comparing spinal 
analgesia, PCA with intravenous morphine, and low thoracic epidural anesthesia 
concluded that patients with the latter had a longer LOSH[7]. 
 
EDA causes an extended sympathetic block, which may compromise tissue 
perfusion. The adequate use of vasopressors to prevent this side effect, provided that 
the patient is not hypovolemic[7], allows for EDA to be safely used and to its full 
potential[8]. This adverse effect appears to be attenuated using a combination of low-
dose local analgesics and opioids[7]. Other concerns regarding EDA lie with the fact that 
up to one-third of epidurals are dysfunctional, possibly due to catheter misplacement, 
inadequate dosing or pump failure. To ensure that the catheter is well placed, sensory 
blockage should be tested previously to anesthesia induction[8].  
 
Perioperative transversus abdominis plane (TAP) blocks have been used in 
laparoscopic colonic surgery, alongside intravenous paracetamol, to cover lower 
abdominal incisions. TAP blocks have the disadvantage of being short-acting and that no 
significant RCT has yet compared the use of TAP with epi- or subdural analgesia[7]. 
There is limited information regarding the use of this technique in rectal surgery and 
gastrectomy[8, 9] 
Subarachnoid long-acting local anesthetics and opioids have been successfully used 
for colonic and colorectal resection[9]. A recent study[15], in the context of laparoscopic 
colorectal surgery, concluded that this anesthetic technique allows for earlier 
mobilization and hospital discharge, when compared to EDA[7]. 
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- Fluid management 
Normovolemia is essential for an adequate organ perfusion. Overload of salt/water 
and hypovolemia both increase postoperative complication rates[8]. Use of goal-directed 
fluid therapy using minimally invasive cardiac output monitoring, such as the esophageal 
Doppler (ED), can help optimize fluid management[7, 9]. Use of ED in major surgery has 
demonstrated reduced LOSH and complication rate[8, 9], faster return of bowel function, 
less PONV, and lower incidence of acute kidney injury[7]. Balanced crystalloids have 
proved to be superior to 0.9% saline solution for the maintenance of the electrolyte 
balance, and should therefore be preferred[7-9]. 
Attention to arterial pressure values is especially important when epidural anesthesia 
is administered, due to its effect on vascular tone[7]. Once normovolemia has been 
established, vasopressors such as neosynephrine or low doses of norepinephrine[9], 
should be used to avoid intraoperative hypotension and secure adequate organ 
perfusion. 
Fluid shifts should be minimized by avoiding bowel preparation, maintaining 
preoperative hydration, as well as minimizing bowel handling and exteriorization outside 
the abdominal cavity[7, 9]. Overload of fluids increases the risk of pulmonary interstitial 
edema, postoperative hypoxia and cardiopulmonary complications, and exacerbates 
gastrointestinal edema, which may delay recovery of gut function[16].  
In colorectal surgery, assuring an adequate gut perfusion is highly important for the 
integrity of the anastomosis. It depends on mean arterial pressure and cardiac output, 
since the splanchnic circulation isn’t capable of autoregulation[7, 9]. 
Postoperative intravenous fluids should be minimized to avoid fluid excess. The 
enteral route should be preferably used[7]. 
 
-  Nasogastric intubation 
Strong evidence supports that routine nasogastric (NG) decompression, following 
gastrectomy and colorectal surgery, should be avoided. NG tubes placed during surgery 
(to evacuate air), should be removed before reversal of anesthesia[7-10]. 
Gastroesophageal reflux is increased during laparotomy if NG tubes are used[9], as well 
as complications such as fever, atelectasis and pneumonia[7, 9]. The avoidance of NG 
tubes was associated with a faster return of bowel movements[7-9]. LOSH and gastric 
discomfort also showed data supporting no NG decompression[7].  
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- Maintenance of normothermia 
Numerous meta-analysis and RCTs have related hypothermia (definition <36ºC), 
during major abdominal surgery, with higher rates of would infections, cardiac 
complications, bleeding, pain sensibility[7, 9] and transfusion requirements[8]. Warming 
in the preoperative period is especially beneficial for patients who will be exposed due to 
prolonged anesthetic procedures[7, 8]. Temperature maintenance during procedure can 
be achieved by using forced-air warming blankets, heating mattresses, circulating water 
garment systems[7]; evidence supports that the latter offers superior temperature control 
than forced-air warming systems[8]. Also, intravenous fluids should be warmed prior to 
administration[7]. Patient core temperature should be monitored and maintained in an 
adequate range[7, 9]. Heating or humidifying the carbon dioxide used for insufflation in 
laparoscopic surgery has not improved temperature maintenance or pain scores 
postoperatively[7]. 
 
- Urinary drainage 
Bladder drainage (BD) is used during and after major abdominal surgery to monitor 
urine output and prevent urinary retention[7]. Increased BD duration is associated with 
increased rates of urinary tract infection (UTI) [7]. Early removal is recommended, ideally 
≤24h postoperatively[8, 9]. If EDA is used, there is an increased risk of urinary 
retention[17], but, after 24h of catheterization, this risk is low[9].  
Several RCTs have reported that suprapubic catheterization, compared to 
transurethral, causes less discomfort and is associated with lower rates of UTI, however, 
the duration of catheterization in these studies was ≥ 4 days[7-9]. This method is 
recommended for patients with increased risk of prolonged postoperative urinary 
retention[9]. 
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Postoperative Items 
 
- Perianastomotic Drainage 
 
ERAS Society Guidelines for perioperative care in elective gastrectomy, colonic and 
rectal surgery agree that abdominal drains should be avoided to reduce drain-related 
complications and reduce LOSH[7-9]. Studies presented in the gastrectomy guidelines 
state that, after gastrectomy, there is no significant difference in postoperative course, 
namely in time to first bowel movement, oral intake of light diet or LOSH between 
patients in whom drains were and were not used. In fact, it is even defended that 
drainage increases LOSH, postoperative morbidity, time to oral intake and causes more 
frequent reoperations[8]. 
 
In colorectal surgery, it was costume to drain the abdominopelvic cavity to prevent 
accumulation of fluids and anastomotic leakage. However, studies have found that the 
use of drains after colorectal surgery doesn’t affect the rate of anastomotic dehiscence 
or overall outcomes[7, 9]. ERAS Society Guidelines for perioperative care in elective 
colonic surgery state that drainage systems are a setback to independent 
mobilization[7]. 
 
- Analgesia 
Adequate postoperative pain management may reduce the extent of surgery-induced 
immunosuppression and inflammation. Patients who experience adequate analgesia, 
demonstrate decreased levels of pro-inflammatory cytokines and increased lymphocyte 
activity[6]. Postoperative analgesia is based on a multimodal regimen that aims to avoid 
the use of opioids[7], due to their multiple adverse effects, which may prolong the LOSH 
[12]. 
When EDA is used in abdominal surgery, it should be maintained for at least 48h and, 
after a successful stop test, replaced by oral analgesia. If necessary, EDA may be 
prolonged[8]. In the context of colorectal surgery, the aim is to remove the catheter ≈ 48-
72h postoperatively, by the time the patient has had bowel movements[7, 9]. In rectal 
surgery, there is extensive tissue dissection and many patients will even have 
preoperative pain which may be neuropathic, partially due to neoadjuvant treatments, 
which will difficult pain management and require a multi-pharmacological approach that 
includes, for example, the combination of EDA with systemic opioids[9]. 
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A RCT[18], for patients submitted to gastrectomy in gastric cancer context, concluded 
that patient-controlled EDA is more effective in pain control, and in reducing stress 
response, than patient-controlled intravenous analgesia, enabling a faster return of 
normal bowel activity[8]. 
In the context of laparoscopic surgery, the duration of postoperative pain that requires 
major analgesics is much shorter than for open surgery, which allows for discharge as 
soon as 23h following surgery[7]. The faster recovery associated with this technique, 
allows for toleration of early feeding, which implies that analgesic requirements can be 
met through oral multimodal analgesia, avoiding the need for regional blocks or strong 
analgesics[7].  
Multimodal analgesia with paracetamol and non-steroidal anti-inflammatory drugs 
(NSAIDs) has shown to spare opioid use by 30%[9]. Paracetamol may be administered 
up to 4 times a day, in an intravenous preparation of 1g. Clinical trials, in colorectal 
surgery, have related the use of NSAIDs (diclofenac and celecoxib) with an increased 
risk of anastomotic dehiscence[7, 9]. Nowadays, there isn’t enough evidence supporting 
that NSAIDs should be abandoned, more studies regarding this question are needed[7]. 
No medication has yet been recommended for routine use[7, 9], however, there are 
several ongoing studies on opioid alternatives for the relief of postoperative pain[7]. 
 
- Control of glucose 
In surgical stress context, there is a generalized catabolic, hyperglycemic response 
that leads to insulin resistance[4, 5]. Insulin resistance is associated with increased 
morbidity and mortality after major gastrointestinal surgery[7, 8]. Hyperglycemia is a 
major predictor of adverse post-surgical outcomes, exerting inflammatory action and 
possibly increasing predisposition to infection. Hypoglycemia is equally dangerous as 
this state adversely affects the circulatory and both the autonomic and central nervous 
systems[19]. 
Several ERAS items attenuate insulin resistance, the most obvious ones being: no 
preoperative fasting and MBP; oral CHO treatment and stimulation of bowel movements 
through optimal fluid balance; avoidance of systemic opioids; early mobilization; and 
lessening of the overall stress response by using EDA whenever possible[7, 8]. These 
treatments have the added advantage of not carrying risk of hypoglycemia[7]. 
Treatment of hyperglycemia in postsurgical patients in the intensive care unit (ICU) 
may require the need for insulin, however, this carries the risk of hypoglycemia and, 
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therefore, should only be used when strictly necessary[7]. The optimal target glucose 
levels remain uncertain[7-9]. 
 
- Prevention of nausea and vomiting 
PONV following a standard anesthetic procedure using inhalational anesthetics and 
opioids, and without any PONV prophylaxis, affects up to 30% of all surgical patients. 
PONV is an important cause of delay in postoperative feeding and recovery[9]. There 
are several PONV scoring systems (e.g. Apfel score) stratifying patients from low-to-high 
risk groups. These scoring systems serve to help guide antiemetic prophylaxis, and in 
several RCTs have proven to reduce PONV, however, they still haven’t been widely 
implemented in routine practice[7]. Multimodal regimens should be adopted in patients 
with ≥2 risk factors undergoing major colorectal surgery or gastrectomy[8, 9]. A 
multimodal approach to PONV includes antiemetic medication and non-pharmacological 
techniques, as the avoidance of inhalational anesthetics and of increased propofol doses 
in induction/maintenance, minimal preoperative fasting, carbohydrate loading and 
adequate hydration[7].  
 
- Perioperative nutritional care 
An early resumption of normal oral feeding following major abdominal surgery is 
associated with a decreased rate of infectious complications and faster recovery, 
however early feeding seems to be associated with an increased risk of vomiting[9].  
An RCT, in colorectal surgery context, that combined preoperative treatment with oral 
CHO, EDA and early oral feeding showed an improved nitrogen equilibrium whilst 
maintaining normal glucose concentrations, without the need for insulin administration[7]. 
ERAS Society guidelines for patients submitted to rectal surgery, recommend that this 
group of patients begin oral ad libitum diet 4h after surgery [9], whilst ERAS Society 
guidelines for patients who underwent colonic surgery state that, in the postoperative 
phase, patients can drink and eat normal hospital food, immediately after recovery from 
anesthesia[7]. Early oral diet has been shown to be safe in patients with a non-diverted 
colorectal anastomosis[9], not affecting the risk of anastomotic dehiscence[7]. There is 
doubt if normal food intake is enough to prevent postoperative weight loss and, 
therefore, it is recommended that patients be offered oral nutritional supplements to 
maintain adequate protein and energy intake[7].  
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Patients subjected to total gastrectomy are probably at a greater risk of malnutrition 
and cachexia at the time of surgery[8]. All patients with risk of malnutrition/nutrient deficit 
should receive special nutritional considerations. In severely malnourished patients, 
supplements have a greater effect if initiated 7-10 days preoperatively[7]. A prospective 
observational study[20] of an ERAS program for colorectal surgery concluded that 
malnourished patients were at risk for delayed recovery of gastrointestinal function, 
prolonged LOSH and increased postoperative morbidity. 
No trial has reported adverse effects from the attempt of introducing early introduction 
of oral feeding in patients who underwent gastrectomy[8]. ERAS Society[8] 
recommendations for gastrectomy state that patients should be offered drinks and food 
at will from postoperative day (POD) 1, with the advice to begin cautiously and increase 
intake according to tolerance. Malnourished patients or patients unable to meet 60% of 
daily requirements by POD6, should be given nutritional support. 
In several studies in the context of traditional care, immunonutrition diets (special 
preparations to enhance immune function in surgical patients) have shown to reduce the 
rate of complications and shorten LOSH, but results are heterogeneous. Evidence 
suggests that it is more effective in malnourished patients. There are no RCTs 
conducted in the ERAS setting[7].  
 
- Stimulation of gut movement and prevention of postoperative ileus 
Postoperative ileus is one of the most common occurrences after abdominal surgery, 
causing delayed recovery, increased LOSH and medical costs[21]. The elimination of 
ileus, allows for earlier initiation of enteral nutrition, which is essential to reduce risk of 
infection[5]. Strategies to reduce the risk of postoperative ileus, included in the ERAS 
pathway, are balancing fluids, avoiding nasogastric tubes[7, 9], opioid analgesia, and 
PONV[2, 9]. 
EDA, compared with intravenous opioid analgesia is highly effective in reducing ileus 
occurrence[7]. Laparoscopic colonic resection is also associated with a faster return of 
gut movement, when compared to laparotomy[7, 9]. 
Use of oral laxatives such as oral magnesium oxide or bisacodyl has demonstrated, 
in different RCTs, a 1-day reduction in time to first defecation. Other outcomes (toleration 
of oral food, LOSH, morbidity and mortality) weren’t altered. In colonic resection, 
administration of oral laxatives has been associated with faster normalization of 
gastrointestinal transit[7, 9]. No RCTs to this matter have been conducted specifically in 
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rectal surgery, so further studies are needed[9]. Oral alvimopan, approved for clinical 
use in postoperative ileus, has shown to accelerate gastrointestinal recovery, whilst 
reducing the LOSH in patients who underwent open colonic resection, having 
postoperative opioid analgesia[7]. Current recommendations state that oral laxatives 
should only be used when opioid analgesia is administered[7]. It is not yet known if 
stimulant laxatives are associated with an increased risk of anastomotic dehiscence, 
further studies are necessary[9]. 
Chewing gum is a safe strategy that seems to have a positive effect on postoperative 
duration of ileus after gastrointestinal surgery[7], reducing time to first bowel movement 
by 1-day[9]. This strategy has shown no impact on LOSH[9]. Efficacy on colorectal 
surgery has been demonstrated, but RCTs specifically concerning gastrectomy are 
lacking[8]. 
 
- Early mobilization 
Prolonged bed rest is a risk factor for several complications, such as 
thromboembolism, prolonged ileus, increased insulin resistance, loss of muscle and 
strength, pulmonary depression and reduced tissue oxygenation[7, 9]. Early mobilization 
should be encouraged since the first postoperative day, but for a limited number of 
hours[7-9]. 
Available RCTs show no direct clinical advantage of early mobilization, however 
disadvantages of prolonged immobilization are well supported[7]. 
 
Postdischarge Items 
 
- Audit of compliance and outcomes 
Auditing of compliance and outcomes is the last phase of the ERAS protocol. Regular 
auditing and standard measuring is essential to determine clinical outcome and confirm 
the adequate implementation of the protocol. It is crucial though to distinguish an 
unsuccessful implementation from lack of aimed results[8]. 
Auditing ERAS protocols has three main dimensions: measurement of clinical 
outcomes such as LOSH, complication and readmission rates; evaluation of patient 
experience and functional recovery; assessment of degree of compliance[7]. 
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The ERAS Society has created an online interactive software, the ERAS® Interactive 
Audit System, to facilitate protocol implementation. This tool not only collects data on the 
patient, treatment and outcomes, but also provides relevant feedback on clinical 
outcomes that are important for the patient and the healthcare team[7]. 
Systematic audit has shown to improve compliance and clinical outcomes[8], and 
helps to understand where there is space for modifications and improvements. 
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Outcomes 
 
Colonic Surgery 
 
A comprehensive medical record review, developed by Haverkamp et al. (2012) [22] 
for laparoscopic colectomy, stated a significant difference in LOSH in patients who 
received the ERAS perioperative care (median: 4 days vs 6 days, p<0.007). Time to 
return of bowel function was 1 day less in the ERAS group (p<0.001). No significant 
differences were noted in postoperative procedure-related complications, 30-day 
morbidity and mortality, readmission and reoperation rates. Haverkamp et al. (2012) [22] 
suggest that these results are the effect of the combination of the ERAS protocol with 
laparoscopic colectomy. The design of this study is limited by the fact that it lacks both 
blinding and randomization, but results are in agreement with data from other studies.  
Bakker et al. (2015) [23] studied, over the course of 8 years, the impact that 
adherence levels to ERAS protocols had on LOSH, following colon cancer resection, 
concluding that they relate inversely. Years with high adherence to protocol had a 
shorter LOSH than years with low adherence (5.7 days vs 7.3 days, p<0.001). It was 
noted, however, that there was a variation in the percentage of laparoscopic resections 
over the 8 years, which may have influenced results on LOSH. Cakir et al. (2013) [24] 
also reported that strict adherence to the ERAS protocol resulted in lower LOSH and 
improved outcomes in colon surgery for malignancy. In colorectal laparoscopic surgery, 
Pisarska et al. (2016) [25] reported consistent findings by showing that improvement of 
protocol compliance leads to better treatment results and convalescence parameters, 
even when groups with high and very-high compliance rate are compared. Pisarska et 
al. (2016) [25] only analyzed short-term results, whereas Gustafsson et al. (2013)  [26] 
demonstrated that the risk of 5-year cancer-specific death in colorectal cancer is lower 
by 42% in groups with ≥70% compliance in comparison to <70%. Although this last study 
demonstrates a striking relationship between adherence to protocol and cancer survival, 
this may not imply a cause and effect association between them – the study doesn’t 
present evidence of mechanisms behind this effect. Several other studies have 
demonstrated that an improved adherence to the ERAS protocol, is associated with 
lower LOSH and improved clinical outcomes following colorectal surgery[27-30]. 
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Rectal Surgery 
 
Recently, two cohort studies comparing ERAS and conventional perioperative care 
reported similar results: Teeuwen et al. (2011) [31] studied results in open rectal surgery, 
and Huibers et al. (2012) [32] in laparoscopic total mesorectal excision for rectal cancer. 
Both studies showed significantly shorter LOSH in the ERAS group [(median: 8 days vs 
12 days, p<0.005) and (median: 7 days vs 10 days, p<0.001), respectively], with no 
significant difference in mortality, morbidity, and readmission rates between groups. 
Functional recovery was also faster in the ERAS groups, with reduced time to first bowel 
movement (p<0,001, for both studies). Teeuwen et al. (2011) [31] noted a trend towards 
more readmissions in the ERAS group, however this difference was not significant 
(17.1% vs 7.3%; p<0.203). While these studies demonstrated a benefit in terms of LOSH 
in the ERAS group, caution must be exercised in interpreting these results due to their 
lack of randomization, which gives room for potential bias and confounding. 
 
Colorectal Surgery 
 
In a RCT, Mari et al. (2016) [33] demonstrated that the ERAS protocol, applied to 
colorectal laparoscopic procedures, reduces the surgical stress response by diminishing 
levels of important proinflammatory elements, more specifically IL-6 and C-reactive 
protein. This attenuates the liver's protein synthesis switch from physiological to acute 
phase inflammatory proteins, allowing for an earlier liver function resumption. 
Ren et al. (2012)  [34] concluded, in a 597-patient RCT, that the ERAS protocol 
attenuates the surgical stress response, by reducing the postoperative insulin resistance 
index, and cortisol and cytokine levels in the ERAS group, comparing with the control 
group (p<0.001). The ERAS group had decreased LOSH (5.7 ± 1.6 days vs 6.6 ± 2.4 
days) in comparison with the controls. This study, however, modified one item of the 
ERAS protocol: traditional Chinese herbal medicine with acupuncture was used to 
promote gut motility, instead of common drugs such as magnesium oxide. It is not known 
to what extent this may have influenced results. 
Zhuang et al. (2013) [35], in a meta-analysis of 13 RCTs (total 1910 patients) found 
that, in comparison to conventional care, ERAS programs in colorectal surgery are 
associated with significantly lower LOSH (weighted mean difference, -2.44 days; 95% 
CI, -3.06 to -1.83 days; p<0.00001). No significant differences were found for 
readmission rates, surgical complications and mortality. This review found several other 
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studies with consistent conclusions in colorectal surgery, reporting that ERAS programs 
reduce LOSH [36-42]. Shida et al. (2017) [43] found these same results in patients 
operated for obstructed colorectal cancer. Keane et al. (2012) [37] added that time to 
tolerate light diet and first bowel movements were also significantly reduced in the ERAS 
group.  
In a retrospective review, Smart et al. (2012) [44], found that deviation from certain 
ERAS items at the end of POD1 predicted a delayed discharge after colorectal surgery 
and consequent ERAS failure: sustained intravenous fluid infusion, dysfunctional 
epidural, failure to mobilize, vomiting demanding nasogastric tube insertion and re-
insertion of urinary catheter, were strongly associated with delayed discharge.  
In an interesting study, Shida et al. (2015) [45], studied if the lower LOSH associated 
with the implementation of ERAS programs in colorectal cancer patients is compatible 
with a better outcome from the patients’ point of view. To do so, a 40-item quality of 
recovery score (QoR-40) was used. QoR-40 measures five dimensions: physical 
comfort, physical independence, emotional state, psychological support and pain, on the 
preoperatory and on POD 1, 3, 6 and one month later. On POD6 the global QoR-40 was 
not significantly different from the baseline level (p=0.06), and one month after surgery 
the score was almost the same as the baseline score (p=1.00).  
A meta-analysis developed by Keane et al. (2012) [37] for patients undergoing 
colorectal surgery, concluded that median primary LOSH (duration of postoperative 
hospital stay until discharge) and total LOSH (primary LOSH plus any additional days 
during hospital readmission) were significantly shorter in the ERAS group by one 
(p<0.004) and three days (p<0.003), respectively, than in the conventional care group. In 
a subgroup analysis for patients undergoing colonic and rectal surgery, it was noticed 
that in the latter subgroup, differences in length of stay were less pronounced, probably 
due to special requirements of this group of patients, namely regarding stoma 
management and urinary catheter removal. 
Pędziwiatr et al [46] investigated if there were differences in short-term outcomes 
between laparoscopic surgery for colonic and rectal carcinoma, in the context of an 
ERAS program and concluded that LOSH was significantly lower for patients treated for 
colonic cancer than for those treated for rectal cancer (median LOSH: 4 versus 5; p < 
0.0464). No statistical difference was found in postoperative complications between 
groups, nor in the 30-day readmission rates. The study points out as explanations for 
this difference the fact that there was a higher percentage of patients with stomas in the 
rectal group, which may prolong LOSH once these patients require training on how to 
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handle the stoma; and the significantly increased use of MBP and postoperative 
drainage in the rectal cancer group. 
Gastrectomy 
 
Unlike with colorectal surgery, ERAS protocols have been less implemented in gastric 
surgery, and, consequently, there are less studies in this field. 
The works published on this area, show that the ERAS protocol can be safely 
implemented for gastric cancer surgery[47, 48]. Makuuchi et al. (2017) [49], in a 300-
patient case-control study, concluded that the use of the ERAS protocol for gastrectomy 
in patients with gastric cancer shortened LOSH by 1 day (p < 0.001) without increasing 
complications. The main reason for the shortened stay being the introduction of oral 
feeding one day earlier. This approach was safely adopted without increased incidence 
of anastomotic leakage.  
Abdikarim et al. (2015) [16], in an RCT conducted in patients submitted to 
laparoscopic assisted radical gastrectomy, showed that time to first ambulation, oral food 
intake, and time do defecation were significantly sorter in the ERAS group, compared to 
the conventional one (p = 0.04, 0.003, 0.01 respectively). LOSH was also significantly 
lower in the ERAS group (6.8 ± 1.1 days versus 7.7 ± 1.1 days, p=0.002). Incidence of 
complications between groups wasn’t significantly different (p = 1). 
Jeong et al. (2016) [50] found that female sex and age (≥ 65years) were significantly 
associated with a delay in recovery of oral intake, and that total gastrectomy was 
significantly associated with delayed achievement of adequate pain control. 
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DISCUSSION  
 
It was noted that, for studies evaluating the same operated organ (stomach, rectum or 
colon), works related to laparoscopic surgery, when compared to laparotomy, showed 
lower LOSH[37]. Although this tendency was noticed, no definite conclusions can be 
drawn, nor is this the aim of the present review. It is also important to consider that in 
studies comparing ERAS to conventional care in terms of outcomes, if laparoscopic 
surgery is significantly more common in the ERAS group, this may confound results[37, 
49]. 
In most patients, achieving total protocol compliance isn’t possible. Even in centers 
that use ERAS protocols on a routine basis, compliance rate round 60-80%[25]. Many 
studies do not specify the compliance rate of the ERAS protocols and, between the ones 
who do, there is lack of uniformity in compliance definitions, which are frequently defined 
by different cutoff points for common analyzed parameters. A good example of this lies 
in the definition of early mobilization, which is subjectively determined by authors [25]. A 
lack of standardization may result in bias when trying to evaluate overall compliance 
rates. 
Most studies concerning ERAS protocols in colorectal surgery include heterogeneous 
groups of patients operated for colonic/rectal disease, creating a potential bias. There is 
lack of research focusing specifically on the outcomes of rectal and colonic surgery, 
under ERAS programs. Each group has special postoperative requirements[37]. Namely 
regarding urinary catheterization. Rectal dissection involves a greater risk of pelvic 
autonomic neuropraxia, making this group of patients more likely to suffer urinary 
retention after and anticipated catheter removal. In addition to this, this type of surgery is 
more likely to require stoma formation. Stoma-related complications are a common 
cause for delay in discharge. It seems that rectal surgery patients have longer LOSH 
than colonic surgery patients, but that they equally benefit from the implementation of the 
ERAS protocols. 
All studies that came up in the PUBMED search for this literature review relate to 
cancer related gastrectomies[16, 47-50]. Therefore, further studies are needed to 
conclude if the ERAS protocols are safe and effective in gastrectomies due to a different 
etiology. 
Teeuwan et al. (2011) [31], in a study focused on rectal surgery patients, noticed a 
trend towards an increased readmission rate in the ERAS group, although the difference 
was not significant. This raises the question if early discharge is likely to raise 
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readmission rates. An adequate use of proper discharge criteria should prevent 
increased readmission rates in fast-track surgery. Other than this, several RCTs[16, 31, 
49] studying the impact of the ERAS protocols did not include the discharge criteria in 
the publication. It is important for the discharge decision to be made according to 
standardized criteria and by clinicians who are not involved in the study, to secure that 
this decision is solemnly based on the patients’ condition, and not influenced by the fact 
that the patient was randomized to the ERAS program.  
Given that factors such as sex and age influence recovery time after gastrectomy[50], 
studies with uneven samples for these two aspects, may have achieved lower/higher 
results that are influenced by these factors, and not solemnly dependent on the 
implementation of the ERAS protocol.  
It would be interesting to know which key elements of ERAS protocols are mainly 
responsible for the overall reduction in LOSH, although work developed by Watt et al. 
(2015) [51] states that there is limited evidence of the effect of individual ERAS protocol 
items in reducing the stress response following colorectal surgery. 
Using LOSH as a measure of recovery may be problematic, as this value is 
influenced by several non-clinical factors, including patient expectations, traditions, 
availability of communitarian or familial support, insurance status and discharge 
destination[45]. Furthermore, LOSH is largely dependent on discharge criteria which still 
lack standardized uniformization.   
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CONCLUSIONS 
 
The ERAS pathway has shown to be safe and to improve outcomes in gastrectomy 
(due to gastric cancer) and colorectal surgery, by minimizing length of stay in hospital by 
at least one day as well as time to return of bowel function.  
This was achieved without an increase in complications, readmissions, morbidity and 
mortality rates, whilst maintaining quality of care.  
This multimodal approach reaches optimal perioperative management and results 
when the compliance level is high.  
The implementation of the ERAS pathway in colorectal surgery has shown to 
successfully reduce the stress response to surgery and to help maintain homeostasis 
perioperatively, information is lacking regarding impact from this point of view in 
gastrectomy within a ERAS protocol. 
Conclusions on which ERAS pathway elements contribute the most to a reduction in 
postsurgical hospital stay can’t be made from this review. It seems that the collective 
implementation of the ERAS items is what contributes to a significant impact in length of 
hospital stay, as opposed to the implementation of the ERAS items individually.  
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